Congress passed a law earlier this year to help people on Medicare save an estimated $6.7 billion between 2020 and 2027 on their prescription drugs.
It requires drug manufacturers to provide a bigger discount on brand-name drugs to beneficiaries who fall into the Medicare Part D coverage gap known as the doughnut hole. More than 29,000 Nebraska seniors will benefit from lower drug costs under the law.
But now, the big drug companies want Congress to break the deal so they can rake in $4 billion more in profits over 10 years. This industry is the last one that needs to make more money off of seniors and taxpayers.
A deal is a deal. AARP’s 200,000 members in Nebraska are not going to sit by and let the pharmaceutical giants gut the law.
On behalf of AARP members in our state and across the country, we call upon Congress to stand by the law it passed and make good on the deal to lower drug costs for seniors.
Suzan DeCamp, Omaha
AARP Nebraska Volunteer Federal Issues Coordinator